Literature DB >> 12877551

Cystocin, a novel antibiotic, produced by Streptomyces sp. GCA0001: biological activities.

Hei Chan Lee1, Kwangkyoung Liou, Dae Hee Kim, Sun-Yub Kang, Jin-Suk Woo, Jae Kyung Sohng.   

Abstract

Cystocin belongs to the class of nucleoside antibiotics from Streptomyces sp. GCA0001. Cystocin showed good activity against gram-positive bacteria, but showed less activity against the gram-negative bacteria. Cystocin exhibited about two to four folds higher activity than puromycin. Especially, cystocin shows relatively strong activity against Streptococcus strains. Cystocin shows quite potent antitumor activity against all of the cells tested showing IC50 values of 0.10 to 0.14 microg/mL. This in vitro result indicates that the cytotoxocity of cystocin is two ten folds more active than puromycin's.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12877551     DOI: 10.1007/bf02976859

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  1 in total

1.  Actinomycetes from the Red Sea Sponge Coscinoderma mathewsi: Isolation, Diversity, and Potential for Bioactive Compounds Discovery.

Authors:  Yara I Shamikh; Aliaa A El Shamy; Yasser Gaber; Usama Ramadan Abdelmohsen; Hashem A Madkour; Hannes Horn; Hossam M Hassan; Abeer H Elmaidomy; Dalal Hussien M Alkhalifah; Wael N Hozzein
Journal:  Microorganisms       Date:  2020-05-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.